Advertisement

GAA
Soccer
Rugby
Golf
Racing
More

More

Upgrade Subscribe Sign in

Subscribe to The 42

Unlock unlimited access

See sport differently with our news, analysis, podcasts and storytelling

More Sports

Fitness
MMA
Other

Sport Features

Rugby Weekly
Editor's Picks
Quizzes
Behind the Lines

Partner Publications

The latest Irish and international breaking news, reports and coverage

A platform helping fund the type of in-depth journalism that the public wants to see

Subscribe to The 42

Unlock unlimited access

See sport differently with our news, analysis, podcasts and storytelling

More Sports

Fitness
MMA
Other

Sport Features

Rugby Weekly
Editor's Picks
Quizzes
Behind the Lines

Partner Publications

The latest Irish and international breaking news, reports and coverage

A platform helping fund the type of in-depth journalism that the public wants to see

# royalty pharma

Advertisement

All time

BID

Royalty gives up bid for Irish biotech firm Elan

18 Jun 2013

5.4k

Content copyright © Journal Media Ltd. 2024 Registered in Dublin, registration number: 483623. Registered office: 3rd floor, Latin Hall, Golden Lane, Dublin 8.

Please note that The 42 uses cookies to improve your experience and to provide services and advertising. For more information on cookies please refer to our cookies policy.

Featured

About Us
We're Hiring!
Contact Us
Advertise With Us
The Journal FactCheck

Policies

Terms of Use
Cookies & Privacy
Advertising
Comments
Copyright
Competition

The 42 supports the work of the Press Council of Ireland and the Office of the Press Ombudsman, and our staff operate within the Code of Practice. You can obtain a copy of the Code, or contact the Council, at www.presscouncil.ie, PH: (01) 6489130, Lo-Call 1800 208 080 or email: info@presscouncil.ie

News images provided by Alamy and RollingNews.ie unless otherwise stated. Irish sport images provided by Inpho Photography unless otherwise stated. Wire service provided by AFP and Press Association.

Journal Media does not control and is not responsible for user created content, posts, comments, submissions or preferences. Users are reminded that they are fully responsible for their own created content and their own posts, comments and submissions and fully and effectively warrant and indemnify Journal Media in relation to such content and their ability to make such content, posts, comments and submissions available. Journal Media does not control and is not responsible for the content of external websites.

Switch to Mobile Site

Switch to Desktop Site

Report an error, omission or problem:

Message:

Your Email (optional)

Create Email Alert

Create an email alert based on the current article

Email Address

One email every morning As soon as new articles come online

Sign in or create
a free account

To continue reading create a free account

Or sign into an existing account